Citigroup’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,252
| Closed | -$64.8K | – | 4873 |
|
|
2025
Q1 | $64.8K | Sell |
24,252
-22,841
| -49% | -$61K | ﹤0.01% | 4034 |
|
|
2024
Q4 | $166K | Buy |
47,093
+22,157
| +89% | +$78K | ﹤0.01% | 3694 |
|
|
2024
Q3 | $118K | Buy |
24,936
+17,349
| +229% | +$82.2K | ﹤0.01% | 3923 |
|
|
2024
Q2 | $35.7K | Buy |
+7,587
| New | +$35.7K | ﹤0.01% | 4044 |
|
|
2018
Q3 | – | Sell |
-1
| Closed | – | – | 5019 |
|
|
2018
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4957 |
|
|
2018
Q1 | – | Sell |
-4
| Closed | -$1K | – | 4890 |
|
|
2017
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 4866 |
|
|
2017
Q3 | $2K | Hold |
4
| – | – | ﹤0.01% | 4479 |
|
|
2017
Q2 | $4K | Sell |
4
-1
| -20% | -$1K | ﹤0.01% | 4359 |
|
|
2017
Q1 | $4K | Hold |
5
| – | – | ﹤0.01% | 4505 |
|
|
2016
Q4 | $5K | Hold |
5
| – | – | ﹤0.01% | 4637 |
|
|
2016
Q3 | $5K | Hold |
5
| – | – | ﹤0.01% | 4630 |
|
|
2016
Q2 | $11K | Hold |
5
| – | – | ﹤0.01% | 4456 |
|
|
2016
Q1 | $7K | Hold |
5
| – | – | ﹤0.01% | 4857 |
|
|
2015
Q4 | $13K | Hold |
5
| – | – | ﹤0.01% | 4669 |
|
|
2015
Q3 | $23K | Hold |
5
| – | – | ﹤0.01% | 3972 |
|
|
2015
Q2 | $24K | Hold |
5
| – | – | ﹤0.01% | 4163 |
|
|
2015
Q1 | $22K | Hold |
5
| – | – | ﹤0.01% | 4360 |
|
|
2014
Q4 | $24K | Hold |
5
| – | – | ﹤0.01% | 4501 |
|
|
2014
Q3 | $31K | Sell |
5
-1
| -17% | -$6.2K | ﹤0.01% | 3983 |
|
|
2014
Q2 | $50K | Hold |
6
| – | – | ﹤0.01% | 3554 |
|
|
2014
Q1 | $149K | Sell |
6
-1
| -14% | -$24.8K | ﹤0.01% | 3145 |
|
|
2013
Q4 | $120K | Buy |
7
+3
| +75% | +$51.4K | ﹤0.01% | 3573 |
|
|
2013
Q3 | $91K | Hold |
4
| – | – | ﹤0.01% | 3207 |
|
|
2013
Q2 | $96K | Buy |
+4
| New | +$96K | ﹤0.01% | 3315 |
|